Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer’s disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics
View ORCID ProfileJohannes C. Michaelian, Christopher C. Rowe, Susan E. Kurrle, Constance Dimity Pond, Michael Woodward, Sharon L. Naismith
doi: https://doi.org/10.1101/2024.07.05.24309974
Johannes C. Michaelian
1Healthy Brain Ageing Program, Brain and Mind Centre and Charles Perkins Centre, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia
Christopher C. Rowe
2Department of Molecular Imaging and Therapy, Austin Health, The University of Melbourne, Victoria, Australia
Susan E. Kurrle
3Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Constance Dimity Pond
4Wicking Dementia Research and Education Centre, University of Tasmania
Michael Woodward
5Department of Continuing Care, Austin Health, The University of Melbourne, Victoria, Australia
Sharon L. Naismith
1Healthy Brain Ageing Program, Brain and Mind Centre and Charles Perkins Centre, School of Psychology, Faculty of Science, University of Sydney, NSW, Australia
Data Availability
The data for this study will not be shared, as we do not have permission from the participants or ethics approval to do so.
Posted July 05, 2024.
Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer’s disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics
Johannes C. Michaelian, Christopher C. Rowe, Susan E. Kurrle, Constance Dimity Pond, Michael Woodward, Sharon L. Naismith
medRxiv 2024.07.05.24309974; doi: https://doi.org/10.1101/2024.07.05.24309974
Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer’s disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinics
Johannes C. Michaelian, Christopher C. Rowe, Susan E. Kurrle, Constance Dimity Pond, Michael Woodward, Sharon L. Naismith
medRxiv 2024.07.05.24309974; doi: https://doi.org/10.1101/2024.07.05.24309974
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (687)
- Anesthesia (184)
- Cardiovascular Medicine (2732)
- Dermatology (234)
- Emergency Medicine (412)
- Epidemiology (12380)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4241)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2742)
- Health Policy (1015)
- Hematology (369)
- HIV/AIDS (875)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (451)
- Neurology (4023)
- Nursing (216)
- Nutrition (597)
- Oncology (2117)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6638)
- Radiology and Imaging (1443)
- Respiratory Medicine (885)
- Rheumatology (420)
- Sports Medicine (350)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)